Stay updated on RC48-ADC in Low HER2 Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the RC48-ADC in Low HER2 Breast Cancer Clinical Trial page.

Latest updates to the RC48-ADC in Low HER2 Breast Cancer Clinical Trial page
- CheckyesterdayNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check23 days agoNo Change Detected
- Check31 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3. This appears to be a minor software update with no visible changes to study content.SummaryDifference0.0%

- Check52 days agoChange DetectedRevision label updated from v3.4.1 to v3.4.2. The study details page content remains unchanged.SummaryDifference0.0%

- Check59 days agoChange DetectedVersion bump from v3.4.0 to v3.4.1. No visible changes to the study details page.SummaryDifference0.0%

- Check82 days agoChange DetectedRevision label updated from v3.3.3 to v3.3.4. No substantive study information appears to be modified.SummaryDifference0.0%

- Check96 days agoChange DetectedThe page now includes an administrative update showing the last known status with sponsor RemeGen Co., Ltd.; date 2023-12; verification status 'Verified'; and 'Unknown status'. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

Stay in the know with updates to RC48-ADC in Low HER2 Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the RC48-ADC in Low HER2 Breast Cancer Clinical Trial page.